Moderna seals pact with Life Edit Therapeutics to tackle genetic diseases with mRNA-based gene editing 23-Feb-2023 By Jonathan Smith The messenger RNA (mRNA) specialist Moderna has teamed up with ElevateBio-owned Life Edit Therapeutics to develop gene editing therapies that are delivered into patients in vivo.
ElevateBio closes $170m Series B financing round 09-Apr-2020 By Ben Hargreaves The accelerator for cell and gene therapy startups reveals the closure of its second financing round and how the funds will be used.
Cell and gene therapy boom creates CDMO capacity bottleneck 25-Nov-2019 By Nick Taylor The rapid expansion of the cell and gene therapy pipeline creates constraints on access to contract capacity.
